Our Pipeline
Our pipeline of immune modulators and precision therapies for multiple solid tumors address patient populations in need of better cancer therapies.
Five Prime Programs
Bemarituzumab
FGFR2b antibody
1L gastric/GEJ cancer
FPT155
CD80-Fc Fusion
Multiple tumor settings
FPA150
B7-H4 antibody
Breast, ovarian and endometrial cancers
Multiple tumor settings
Partnered Programs
BMS-986258
TIM-3 antibody
Multiple tumor settings
Multiple tumor settings
Antibody-drug Conjugates
Multiple tumor settings
